Quentin B. B.
- Country
- France
- Department
- Neurologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 14 partner sites.
Specializations
Neuro‑oncology
Investigation of primary and metastatic brain tumours, with emphasis on targeted and immunotherapeutic strategies.
- glioblastoma clinical evaluation
- brain metastasis from lung carcinoma
- meningioma molecular profiling
- primary central nervous system lymphoma treatment optimization
Collaboration with oncology units at Centre Hospitalier De La Cote Basque supports interdisciplinary trial conduct.
Neuroinflammation & Autoimmune Neurology
Focus on immune‑mediated central nervous system disorders and their therapeutic modulation.
- multiple sclerosis disease‑modifying therapies
- relapsing‑remitting multiple sclerosis relapse prevention
- neuromyelitis optica spectrum disorder antibody‑targeted treatment
- autoimmune encephalitis novel immunotherapies
Research integrates biomarkers to personalize immunomodulatory regimens.
Cerebrovascular Disease
Clinical studies aimed at acute stroke management and secondary prevention.
- ischemic stroke acute reperfusion strategies
- intracerebral hemorrhage hemostatic interventions
- atrial fibrillation‑related embolic stroke anticoagulation optimization
- stroke recurrence risk‑factor modification
Efforts include neuro‑imaging endpoints and functional outcome measures.
Neurodegenerative Disorders
Exploration of disease‑modifying approaches for progressive neurodegeneration.
- Alzheimer’s disease amyloid‑targeted agents
- Parkinson’s disease alpha‑synuclein therapeutics
- amyotrophic lateral sclerosis neuroprotective compounds
- frontotemporal dementia tau‑modulating strategies
Trials incorporate cognitive and biomarker endpoints to assess efficacy.
Neuromuscular & Rare Neurological Conditions
Targeted investigations of muscle and peripheral nerve disorders.
- inclusion body myositis immunotherapy assessment
- chronic inflammatory demyelinating polyneuropathy novel agents
- myasthenia gravis complement inhibition trials
- hereditary neuropathy gene‑editing approaches
Study designs prioritize functional outcome scales and quality‑of‑life metrics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.